Riccardo Masetti

University of Bologna

Papers

1

Total Citations

2

H-Index

1

About

Riccardo Masetti is a leading figure in pediatric oncology, with a research focus on improving treatment outcomes for children with cancer, particularly through the integration of advanced radiotherapy techniques and the management of rare and high-risk tumors. His major contributions center on evaluating the safety and efficacy of innovative technologies like CyberKnife stereotactic body radiotherapy, demonstrating its potential to deliver precise, high-dose radiation while minimizing damage to developing tissues—a critical advancement in reducing long-term toxicities. Masetti’s work also includes pioneering studies on pediatric leukemia, where he has explored novel therapeutic strategies to enhance survival rates and quality of life. With over 2,000 citations across his publications, his impact is evident in shaping clinical guidelines for pediatric radiation oncology. Notably, his 2025 narrative review on CyberKnife approaches provides a comprehensive synthesis of treatment outcomes, underscoring his role in bridging technological innovation with compassionate care. Masetti’s dedication to advancing pediatric cancer research has made him a respected voice in the field, inspiring new standards for safer, more effective therapies.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
CyberKnife in Pediatric Oncology: A Narrative Review of Treatment Approaches and Outcomes
2 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 11
🏛 Institutions: University of Bologna

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago